The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies

By Global Cancer Consortium on April 29, 2008 • ( Leave a comment )

ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute […]

Cancer Researchers See the Light: Caliper Life Sciences Intruduces Bioware Ultra

By Global Cancer Consortium on April 17, 2008 • ( 1 Comment )

Five cancer cells were injected subcutaneously into the dorsal region near the thigh of mouse. Tumor growth is monitored weekly by an IVIS Spectrum. The tumor was visible 28 days post implantation; […]

Obese Patients Create New Transportation Opportunities

By Global Cancer Consortium on April 8, 2008 • ( Leave a comment )

Nearly 40 million U.S. adults are classified as obese. Of these, it is estimated that four million are severely obese and 1.5 million are morbidly obese (BMI > 40). A number of […]

Aethlon Seeks to Reinforce Hemopurifier’s Broad-Spectrum Utility with West Nile Studies

By Global Cancer Consortium on April 4, 2008 • ( Leave a comment )

Aethlon Medical’s Hemopurifier has been shown to capture or inhibit the growth of other envelope viruses including HIV, SIV, FIV, Hepatitis C, Measles, Mumps, Influenza, Ebola, Marburg, and Orthopox viruses. Researchers have […]

Delcath Presents Positive Phase II Data on PHP System in Treatment of Inoperable Liver Cancer

By Global Cancer Consortium on April 2, 2008 • ( Leave a comment )

One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often used to limit side effects, which may […]

[Video Profile] Interview with Craig Davenport, President & CEO of Endocare

By Global Cancer Consortium on March 26, 2008 • ( Leave a comment )

Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and cryotherapy. Treatment depends on factors including the […]

Painting the Colon: Early Stage Cancer Detection without Biopsy

By Global Cancer Consortium on March 20, 2008 • ( 2 Comments )

Most cases of colon cancer begin as small noncancerous polyps. Over time these polyps may become colon cancers. Regular screening helps identify polyps before they become cancerous, allowing for prophylactic treatment. According […]

New Insurance Contracts for I-Flow’s ON-Q

By Global Cancer Consortium on March 19, 2008 • ( 1 Comment )

I-Flow Corporation develops ambulatory drug delivery systems for pain management and infusion therapy. The company’s line of compact and portable infusion pumps includes catheters and pain kits to administer medications directly to […]

Posts navigation

‹ Newer 1 … 71 72 73 74 75 76 77 78 79 80 81 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.